Drug intelligence / Profile preview

ubidecarenone

Development stage
Preclinical
Lead developer
Shenyang Dashan Pharmaceutical Technology
Modality
Small Molecules
Administration
Oral
01

Overview

Coenzyme Q10 (ubidecarenone) is a naturally occurring fat-soluble quinone that acts as a critical component of the mitochondrial electron transport chain, facilitating the production of ATP. It also serves as a potent antioxidant, protecting cell membranes and lipoproteins from oxidative damage. Shenyang Dashan Pharmaceutical Technology is developing an oral tablet formulation of coenzyme Q10 primarily for the treatment of cardiovascular diseases, where it is thought to improve myocardial energetics and reduce oxidative stress. While widely available as a dietary supplement, it is also regulated as a pharmaceutical product in various jurisdictions for indications such as heart failure and mitochondrial disorders.

Brand names
QBICURIS-100QBICURIS100QBICURIS 100
Other names
coenzyme Q10 tabletsCoenzyme Q10CoQ10CoQ-10CoQ 10ubiquinoneubidecarenone
02

Targets

SDH (Mitochondrial electron transport chain complex II)Ubiquinol-cytochrome c reductase (Complex III) ubiquinone binding sitesNADH:ubiquinone oxidoreductase subunit family

Beyond the preview

Go deeper on ubidecarenone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ubidecarenone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call